KLH-2109+ Leurprorelin acetate Placebo

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

KLH-2109+ Leurprorelin acetate Placebo
Treatment and conditionWhere it standsTrials
KLH-2109+ Leurprorelin acetate Placebo for leiomyomaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1